Article info

Download PDFPDF
TP53 mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analyses

Authors

  1. Correspondence to Stephanie Lheureux, Division on Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada; stephanie.lheureux{at}uhn.ca
View Full Text

Citation

Mandilaras V, Garg S, Cabanero M, et al
TP53 mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analyses

Publication history

  • Received September 9, 2018
  • Revision received November 25, 2018
  • Accepted November 29, 2018
  • First published January 18, 2019.
Online issue publication 
February 04, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.